Ahuja Nita 4

What Happened

• Nita Ahuja, a director of Abbott Laboratories, received a grant of 2,286 restricted stock units (RSUs) on 2026-04-24. The award is reported at $0.00 acquisition price (typical for RSU grants); no cash was paid by the insider. The RSUs will be settled one-for-one in Abbott common shares upon specified events (see footnote).

Key Details

• Transaction date: 2026-04-24; reported on Form 4 filed 2026-04-28.
• Transaction type/code: Award/Grant (A) — 2,286 RSUs @ $0.00.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: RSUs were granted under the Abbott Laboratories 2026 Incentive Stock Program and will be paid in common shares on the earlier of the director’s separation from service, death, or a change in control.
• Timeliness: Filing was submitted 4/28 for a 4/24 grant, within the standard two-business-day reporting window.

Context

• RSUs are a form of equity compensation that do not convert into actual shares until settlement conditions are met; they are not an immediate purchase or sale. Grants to non-employee directors are common as part of long-term compensation and do not by themselves indicate a near-term buying or selling signal.